Retour sur lavenir.net
   AGEAS 70.650 € (-1,33 %)     LOTUS BAKERIES 10 980.000 € (+1,67 %)     KINEPOLIS GROUP 41.150 € (+1,60 %)     AB INBEV 72.600 € (-1,12 %)     ARGENX SE 772.000 € (0,00 %)     TESSENDERLO 20.950 € (-0,24 %)     BPOST 1.534 € (+0,26 %)     FAGRON 23.300 € (0,00 %)     VAN DE VELDE 29.900 € (0,00 %)     SOLVAY 27.320 € (+3,41 %)     D'IETEREN GROUP 182.100 € (-0,33 %)     PROXIMUS 6.340 € (+0,79 %)     OPTION 4.030 € (-12,20 %)     MELEXIS 66.350 € (-3,42 %)     SYENSQO 72.200 € (+0,91 %)     KBC 121.150 € (-1,34 %)     AZELIS GROUP 11.680 € (+5,89 %)     ELIA GROUP 129.500 € (-4,78 %)     ACKERMANS V.HAAREN 262.800 € (-0,15 %)     WDP 22.580 € (-1,48 %)     UCB 250.600 € (+0,16 %)     UMICORE 20.600 € (+2,28 %)     CMB.TECH 13.860 € (+2,82 %)     CENERGY 21.040 € (+2,94 %)     GIMV 44.550 € (-0,22 %)     TUBIZE-FIN 213.800 € (+1,14 %)     EVS 27.650 € (+0,73 %)     MONTEA 68.300 € (-1,30 %)     AEDIFICA 70.750 € (-1,26 %)     ONTEX GROUP 2.450 € (+6,52 %)     COLRUYT 38.620 € (-0,97 %)     BARCO 7.900 € (-0,13 %)     BREDERODE 102.200 € (-0,39 %)     KBC ANCORA 86.300 € (-0,69 %)     SIPEF 90.200 € (-1,64 %)     TITAN S.A. 51.800 € (0,00 %)     SOFINA 242.600 € (+0,92 %)     XIOR 28.000 € (+0,18 %)     DECEUNINCK 2.175 € (0,00 %)     BEKAERT 42.150 € (-0,24 %)     IMMOBEL 21.300 € (-1,39 %)     GBL 78.250 € (-0,38 %)     VIOHALCO 17.040 € (-1,50 %)     CFE 12.100 € (0,00 %)     RETAIL ESTATES 65.800 € (-0,60 %)     ECONOCOM GROUP 1.405 € (+1,81 %)     ONWARD MEDICAL 2.390 € (-1,44 %)     VASTNED 29.400 € (+0,17 %)     FLUXYS BELGIUM D 20.100 € (-1,47 %)     CIE BOIS SAUVAGE 303.000 € (+0,66 %)     CARE PROPERTY INV. 12.720 € (-0,62 %)     AGFA-GEVAERT 0.383 € (+3,38 %)     ORANGE BELGIUM 22.100 € (+0,45 %)     DEME GROUP 163.400 € (+0,12 %)     IBA 16.120 € (+0,12 %)     ASCENCIO 52.400 € (+0,19 %)     BIOTALYS 2.645 € (-1,12 %)     SOLVAC NOM(RETAIL) 76.000 € (-1,30 %)     CAMPINE 211.000 € (+1,93 %)     RECTICEL 12.140 € (0,00 %)  
   FDJ UNITED 22.770 € (-0,39 %)     HAVAS 18.700 € (0,00 %)     LOUIS HACHETTE 1.774 € (+0,91 %)     LIGHTON 4.065 € (-23,30 %)     NICOX 0.378 € (+0,13 %)     GALP ENERGIA-NOM 19.855 € (+2,82 %)     KERING 286.500 € (+14,37 %)     HERMES INTL 1 478.500 € (-12,80 %)     SANOFI 79.715 € (+0,42 %)     ORANGE 16.955 € (-1,28 %)     THALES 248.300 € (-0,40 %)     AIR LIQUIDE 170.780 € (-1,59 %)     ENGIE 26.310 € (+0,57 %)     TOTALENERGIES 75.620 € (+2,49 %)     ASM INTERNATIONAL 719.400 € (-4,84 %)     PERNOD RICARD 66.940 € (-1,24 %)     AHOLD DEL 34.560 € (-1,09 %)     SOCIETE GENERALE 76.830 € (-0,19 %)     L'OREAL 380.650 € (-0,59 %)     SHELL PLC 38.620 € (+2,03 %)     ABN AMRO BANK N.V. 37.170 € (-1,72 %)     MEDINCELL 26.740 € (+5,94 %)     DASSAULT AVIATION 306.800 € (-1,10 %)     ADYEN 870.800 € (-2,51 %)     DANONE 68.820 € (-4,73 %)     ASML HOLDING 1 383.800 € (-0,33 %)     LDC 113.400 € (-0,87 %)     ARCELORMITTAL SA 59.180 € (+0,20 %)     STELLANTIS NV 5.221 € (+2,96 %)     SOPRA STERIA GROUP 198.700 € (+15,39 %)     BUREAU VERITAS 29.480 € (+7,91 %)     EDP 4.464 € (-0,87 %)     CREDIT AGRICOLE 18.465 € (-1,07 %)     REXEL 35.120 € (-0,93 %)     EDENRED 28.630 € (+1,60 %)     AIRBUS 210.650 € (-0,64 %)     STMICROELECTRONICS 43.570 € (-2,03 %)     ING GROEP N.V. 28.875 € (-0,89 %)     DASSAULT SYSTEMES 20.730 € (-1,33 %)     SOITEC 98.200 € (-1,19 %)     BOUYGUES 46.320 € (-0,45 %)     WOLTERS KLUWER 72.560 € (+0,97 %)     B.COM.PORTUGUES 1.026 € (-2,29 %)     RANDSTAD NV 38.290 € (-0,23 %)     NEXANS 128.300 € (+3,38 %)     SPIE 47.160 € (-0,30 %)     VINCI 118.100 € (-0,59 %)     GTT 190.100 € (+2,20 %)     LVMH 468.000 € (-0,49 %)     HAFFNER ENERGY 0.296 € (+16,11 %)     BE SEMICONDUCTOR 193.800 € (-2,02 %)     Vusion 137.300 € (+5,37 %)     IT LINK 16.300 € (+7,24 %)     CARREFOUR 15.620 € (-2,38 %)     ENTECH 9.380 € (-1,26 %)     BNP PARIBAS ACT.A 107.240 € (-0,89 %)     AXA 44.840 € (-1,60 %)     PUBLICIS GROUPE SA 93.920 € (+0,09 %)     MAISON POMMERY 11.300 € (+2,73 %)     BENETEAU 5.880 € (-1,01 %)  
News Réglementées
03/01/2023 09:30

Empower Clinics Subsidiary Signs Laboratory Services Agreement with US Healthcare Provider for Underserved Americans

MediSure Laboratory will provide clinical laboratory services to Specialist Network of North America as part of recently announced partnership

VANCOUVER, BC / ACCESSWIRE / January 3, 2023 / EMPOWER CLINICS INC (CSE:EPW)(OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, a medical device company and a high complexity medical diagnostics laboratory - today announced that Medisure Laboratory ("Medisure labs") signed a clinical laboratory services agreement with Specialist Network of North America Inc. (SSNA).

The agreement follows the partnership announced on December 7th between Empower and SNNA to launch a healthcare network whose mission is to bring access to quality and affordable specialist healthcare to underserved communities across the US.

The Laboratory Services Agreement will provide SNNA the opportunity to offer its patients a full range of required cardiology screening panels and point-of-care testing products that are integral to diagnosis and the provision of treatment options. Medisure Labs generates new consistent monthly revenue and plays an important role in helping underserved patients.

"This agreement is exactly the type of accretive benefit that I envisioned when Empower partnered with SSNA last month", stated Steven McAuley, Chairman and CEO of Empower Clinics "With Medisure Labs, we have a laboratory that has state-of-the art technology and a pristine operating environment. We continue to aggressively pursue and replicate laboratory service agreements like the one with SSNA to maximize our return on investment in Medisure Laboratory."

This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics

ABOUT SPECIALIST NETWORK OF NORTH AMERICA

https://specnethealth.com/

We are a healthcare network whose mission is to bring access to quality and affordable specialist healthcare to underserved communities across the US. We aim to facilitate the effective and timely delivery of that care by creating and deploying a collaborative network of strategic partnerships including clinics, telemedicine and insurance providers.

ABOUT EMPOWER:

Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, a medical device company and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Media:

Steven McAuley
CEO
s.mcauley@empowerclinics.com
+1 855-855-9058

Investors:

Tamara Mason
Business Development & Communications
t.mason@empowerclinics.com
+1 855-855-9058

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain "forward-looking statements" or "forward-looking information" (collectively "forward looking statements") within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as "plans", "continues", "expects", "projects", "intends", "believes", "anticipates", "estimates", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. Forward-looking statements in this news release include statements regarding: the likelihood or ability for the Company to secure new testing business from SNNA. Such forward-looking statements are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that the Company may be unable to enter into definitive agreements, or close transactions with respect to, proposed future clinic openings; that due diligence with respect to anticipated clinic openings and acquisitions may not be satisfactory to the Company; risks related to delays in permitting or construction; risks related to supply chains and access to labour; that legislative changes may have an adverse effect on the Company's business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; that the Company will be able to commence and/or complete build-outs and tenants improvements for new clinics; general business, economic, competitive, political and social uncertainties; and other factors beyond the Company's control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur on the terms or in the time expected, or at all, or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.

SOURCE: Empower Clinics Inc.



View source version on accesswire.com:
https://www.accesswire.com/733754/Empower-Clinics-Subsidiary-Signs-Laboratory-Services-Agreement-with-US-Healthcare-Provider-for-Underserved-Americans

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière